Juno Therapeutics Viewed As A Sympathy Play On Kite Pharma's KTE-C19

By: via Benzinga
Kite Pharma Inc (NASDAQ: KITE) saw its shares rally sharply in the after hours Tuesday. The reason: Interim results from the Phase II ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.